News
Arix Bioscience Plc - Annual Results 2017
·Successful IPO on the Main Market of the London Stock Exchange in February 2017, raising £112 million. o Led a $45 million Series B investment round for LogicBio Therapeutics. o Co-led a $45 million Series B investment round for Harpoon Therapeutics.
·Successful IPO on the Main Market of the London Stock Exchange in February 2017, raising £112 million. o Led a $45 million Series B investment round for LogicBio Therapeutics. o Co-led a $45 million Series B investment round for Harpoon Therapeutics.